Domestic pharmaceutical companies develop salt-modified drugs of Viread in series
Dong-A ST, Chong Kun Dang, CJ HealthCare and JW Pharmaceutical are developing incrementally modified drugs of Viread(generic name: tenofovir), a chronic hepatitis B treatment.
The pharmaceutical companies have field a trial for (defensive) confirmation of the scope of the right related to the Vi...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
